Alto Neuroscience (ANRO) Interest Expenses (2023 - 2026)

Alto Neuroscience has disclosed Interest Expenses across 4 years of filings, most recently posting $545000.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $545000.0, down 8.86% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.4 million (up 48.49% YoY), and the FY2025 annual result was $2.5 million, up 79.56% from the prior year.
• Interest Expenses came in at $545000.0 for Q1 2026 at Alto Neuroscience, down from $575000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $650000.0 in Q3 2025 to a low of $324000.0 in Q1 2023.
• The 4-year median for Interest Expenses is $356000.0 (2023), against an average of $443000.0.
• Across the five-year window, Interest Expenses jumped 86.25% in 2025 and slipped 8.86% in 2026, its largest moves.
• Alto Neuroscience's Interest Expenses stood at $356000.0 in 2023, then declined by 6.46% to $333000.0 in 2024, then surged by 72.67% to $575000.0 in 2025, then decreased by 5.22% to $545000.0 in 2026.
• The last three Interest Expenses figures came in at $545000.0 (Q1 2026), $575000.0 (Q4 2025), and $650000.0 (Q3 2025), per Business Quant data.